Computer-assisted drug development (CADD): an emerging technology for designing first-time-in-man and proof-of-concept studies from preclinical experiments

Author： Gomeni R.   Bani M.   D'Angeli C.   Corsi M.   Bye A.  

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.13, Iss.3, 2001-06, pp. : 261-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept

By Ku M. Sherry   Dulin Wendy  

Pharmaceutical Development and Technology, Vol. 17, Iss. 3, 2012-06 ,pp. : 285-302

Informa Healthcare

Access to resources Recommend Favorite

Progress of Computer-Aided Drug Design (CADD) of Proteasome Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 23, 2011-12 ,pp. : 2931-2944

Bentham Science Publishers

Access to resources Recommend Favorite

Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications

By  

Current Pharmaceutical Design, Vol. 20, Iss. 36, 2014-11 ,pp. : 5706-5726

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and Proof-of-Concept Efficacy of Inhaled Drug Loaded Nano- and Immunonanoparticles in a c-Raf Transgenic Lung Cancer Model

By  

Current Cancer Drug Targets, Vol. 13, Iss. 1, 2013-01 ,pp. : 11-29

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Data to be Derived from Early-Phase Drug Development: Designing Informative Human Pharmacology Studies

By Cohen Adam  

Clinical Pharmacokinetics, Vol. 47, Iss. 6, 2008-01 ,pp. : 373-381

Adis International

Access to resources Recommend Favorite